Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × KB004 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 94 Radiotherapy 54 Radiation 26 Bevacizumab 16 Magnetic Resonance Spectroscopy 12 Nivolumab 11 Surgical Procedures, Operative 8 Irinotecan 8 Cyclophosphamide 8 pembrolizumab 7 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Radiosurgery 7 O(6)-benzylguanine 7 Flucytosine 7 Chemotherapy, Adjuvant 7 poly ICLC 6 motexafin gadolinium 6 Carmustine 6 sargramostim 5 fludarabine 5 Radiotherapy, Conformal 5 Lomustine 5 Leukapheresis 5 Imatinib Mesylate 5 Hydroxyurea 5 Erlotinib Hydrochloride 5 Drug Therapy 5 vocimagene amiretrorepvec 4 Sorafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03374943 2021-11-04

A Trial of KB004 in Patients With Glioblastoma

Olivia Newton-John Cancer Research Institute

Phase 1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡